"The U.S. Department of Health and Human Services is planning to release a report that will reportedly link autism and acetaminophen use in pregnancy, according to The Wall Street Journal. The department has confirmed a report is in the works, but has not revealed its conclusions. Drug maker Kenvue, which sells acetaminophen under the brand name Tylenol, saw its shares slump following the Journal's report, dropping more than 10% on Friday."
"Some studies have found correlations between taking the common painkiller in pregnancy and the risk of children developing neurodevelopmental conditions. But these studies don't prove a link, and other results suggest otherwise: A 2024 Journal of the American Medical Association (JAMA) study-the largest on acetaminophen to date-found that there was no association between acetaminophen use during pregnancy and increased risk of autism, attention deficit and hyperactivity disorder, or intellectual disability."
HHS is preparing a report that reportedly links prenatal acetaminophen exposure and folate deficiency to autism, while withholding its conclusions. The agency confirmed a report is in progress. Kenvue, maker of Tylenol, experienced a share slump exceeding 10% after the report's emergence. Health Secretary Robert F. Kennedy Jr. has prioritized investigating autism and initiated plans for expanded testing and research. An HHS spokesperson characterized some media reporting as "speculation" and emphasized the use of gold-standard science. Epidemiological studies show mixed results: some find correlations between prenatal acetaminophen and neurodevelopmental risks, while a 2024 JAMA study found no association.
Read at Fast Company
Unable to calculate read time
Collection
[
|
...
]